HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ATP6
mitochondrially encoded ATP synthase 6
Chromosome MT
NCBI Gene: 4508Ensembl: ENSG00000198899.2HGNC: HGNC:7414UniProt: P00846
119PubMed Papers
28Diseases
0Drugs
11Pathogenic Variants
FUNCTIONAL ROLE
Transporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
✓ Swiss-Prot Reviewed
NARP syndromeLeber hereditary optic neuropathyLeigh syndromemitochondrial disease
✦AI Summary

ATP6 encodes subunit a of mitochondrial ATP synthase (Complex V), a critical component of the F0 membrane domain that generates ATP from the proton gradient across the inner mitochondrial membrane 1. ATP6 forms the proton-conducting channel together with subunit c, containing inlet and outlet half-channels that facilitate proton movement from the intermembrane space into the matrix via a Grotthuss mechanism 1. ATP synthesis couples to proton translocation through rotation of the central stalk within the catalytic F1 domain 1. Pathogenic ATP6 variants cause severe mitochondrial diseases with diverse clinical presentations. A 209-patient Leigh syndrome cohort identified MT-ATP6 as the most frequent causative gene, with specific variants (m.8993T>C and m.9176T>C) associated with ≤50% three-year survival 2. Analysis of 218 published MT-ATP6 disease cases revealed that symptomatic carriers had significantly higher heteroplasmy loads and exhibited reduced ATP synthesis rates, preserved ATP hydrolysis, and abnormally increased membrane potential—though no single biochemical feature was universally present 3. A 111-patient natural history study documented infantile-onset disease in 44% of cases with CNS involvement in 93%, muscle in 75%, and eye involvement in 46% 4. ATP6 dysfunction impairs mitochondrial respiration, causing proton accumulation in the intermembrane space, mtDNA release, and inflammasome activation 5. ATP6 variants also manifest as mitochondrial retinopathy with characteristic chorioretinal atrophy patterns 6.

Sources cited
1
ATP6 forms F0 proton-conducting channel with subunit c; contains inlet/outlet half-channels and couples ATP synthesis to central stalk rotation
PMID: 37244256
2
MT-ATP6 most frequent Leigh syndrome gene; specific variants associated with ≤50% three-year survival
PMID: 35094435
3
MT-ATP6 variants show symptomatic carriers with higher heteroplasmy loads; reduced ATP synthesis, preserved ATP hydrolysis, increased membrane potential
PMID: 30763462
4
MT-ATP6/8 deficiency: infantile-onset 44%, CNS involvement 93%, muscle 75%, eye 46%; metabolic biomarkers include elevated lactate/alanine
PMID: 40112238
5
Reduced MT-ATP6 expression impairs complex V activity, causes proton accumulation, mtDNA release, and inflammasome activation
PMID: 39687989
6
MT-ATP6 variants associate with mitochondrial retinopathy showing chorioretinal atrophy patterns
PMID: 34257060
Disease Associationsⓘ28
NARP syndromeOpen Targets
0.76Strong
Leber hereditary optic neuropathyOpen Targets
0.73Strong
Leigh syndromeOpen Targets
0.71Strong
mitochondrial diseaseOpen Targets
0.67Moderate
mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1Open Targets
0.60Moderate
MELAS syndromeOpen Targets
0.57Moderate
MERRFOpen Targets
0.53Moderate
MERRF syndromeOpen Targets
0.52Moderate
Isolated cytochrome C oxidase deficiencyOpen Targets
0.52Moderate
leigh syndrome due to mitochondrial complex iv deficiencyOpen Targets
0.52Moderate
Mitochondrial myopathyOpen Targets
0.49Moderate
inborn mitochondrial myopathyOpen Targets
0.49Moderate
mitochondrial non-syndromic sensorineural hearing lossOpen Targets
0.49Moderate
maternally-inherited spastic paraplegiaOpen Targets
0.46Moderate
maternally-inherited Leigh syndromeOpen Targets
0.46Moderate
Mitochondrial myopathy and sideroblastic anemiaOpen Targets
0.45Moderate
Mitochondrial disease with hypertrophic cardiomyopathyOpen Targets
0.45Moderate
Sensory ataxic neuropathy - dysarthria - ophthalmoparesisOpen Targets
0.45Moderate
Kearns-Sayre syndromeOpen Targets
0.45Moderate
progressive external ophthalmoplegiaOpen Targets
0.44Moderate
Ataxia and polyneuropathy, adult-onsetUniProt
Cardiomyopathy, infantile hypertrophicUniProt
Leber hereditary optic neuropathyUniProt
Leigh syndromeUniProt
Mitochondrial complex V deficiency, mitochondrial 1UniProt
Mitochondrial infantile bilateral striatal necrosisUniProt
Myopathy, lactic acidosis, and sideroblastic anemia 3UniProt
Neuropathy, ataxia, and retinitis pigmentosaUniProt
Pathogenic Variants11
NC_012920.1(MT-ATP6):m.8993_8994invLikely pathogenic
NARP syndrome|Mitochondrial disease
★★★☆2024
NC_012920.1(MT-ATP6):m.8618dupLikely pathogenic
NARP syndrome|Mitochondrial disease
★★★☆2024
NC_012920.1(MT-ATP6):m.9155A>GLikely pathogenic
Mitochondrial disease|Leigh syndrome
★★★☆2022
NC_012920.1(MT-ATP6):m.9185T>CPathogenic
Leigh syndrome|Charcot-Marie-Tooth disease|Mitochondrial disease|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Mitochondrial DNA-Associated Leigh Syndrome and NARP|Charcot-Marie-Tooth disease, type IA|NARP syndrome|MT-ATP6-related mitochondrial disease|Primary Mitochondrial Disorders
★★★☆2022
NC_012920.1(MT-ATP6):m.9176T>CPathogenic
Leigh syndrome|Striatonigral degeneration, infantile, mitochondrial|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Maternally-inherited spastic paraplegia|Mitochondrial disease|Leigh syndrome, mitochondrial|NARP syndrome|MT-ATP6-related disorder|Primary Mitochondrial Disorders
★★★☆2022
NC_012920.1(MT-ATP6):m.9035T>CLikely pathogenic
Progressive cerebellar ataxia|Leigh syndrome|See cases|Leber optic atrophy|Mitochondrial disease|MT-ATP6-related primary mitochondrial disease|NARP syndrome|MT-ATP6-related disorder|Primary Mitochondrial Disorders
★★★☆2022
NC_012920.1(MT-ATP6):m.8969G>ALikely pathogenic
Myopathy, lactic acidosis, and sideroblastic anemia 3|MELAS syndrome|Leber optic atrophy|Mitochondrial disease|not provided|MT-ATP6-related disorder|Primary Mitochondrial Disorders
★★★☆2022
NC_012920.1(MT-ATP6):m.9191T>CLikely pathogenic
Leigh syndrome|Mitochondrial disease
★★★☆2022
NC_012920.1(MT-ATP6):m.9176T>GLikely pathogenic
Leigh syndrome|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|not provided|Leber optic atrophy|Mitochondrial disease
★★★☆2022
NC_012920.1(MT-ATP6):m.8993T>CPathogenic
Leigh syndrome|Ataxia and polyneuropathy, adult-onset|Mitochondrial disease|Mitochondrial complex 5 (ATP synthase) deficiency, mitochondrial type 1|NARP syndrome|not provided|Leber optic atrophy
★★★☆2021
NC_012920.1(MT-ATP6):m.8752_8753insAAAPathogenic
Bicuspid aortic valve
☆☆☆☆
View on ClinVar ↗
Related Genes
ATP5F1AProtein interaction100%ATP5PDProtein interaction100%ATP5MC1Protein interaction100%ATP5MC3Protein interaction100%ATP5PFProtein interaction100%ATP5F1BProtein interaction100%
Tissue Expression6 tissues
Heart
100%
Liver
84%
Brain
51%
Lung
13%
Ovary
11%
Bone Marrow
7%
Gene Interaction Network
Click a node to explore
ATP6ATP5F1AATP5PDATP5MC1ATP5MC3ATP5PFATP5F1B
PROTEIN STRUCTURE
Preparing viewer…
PDB8H9S · 2.53 Å · EM
View on RCSB ↗
RankingsWhere ATP6 stands among ~20K protein-coding genes
  • #3,955of 20,598
    Most Researched119 · top quartile
  • #2,748of 5,498
    Most Pathogenic Variants11
Genes detectedATP6
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
METTL4-Mediated Mitochondrial DNA N6-Methyldeoxyadenosine Promoting Macrophage Inflammation and Atherosclerosis.
PMID: 39687989
Circulation · 2025
1.00
2
Leigh Syndrome: A Study of 209 Patients at the Beijing Children's Hospital.
PMID: 35094435
Ann Neurol · 2022
0.90
3
MT-ATP6 mitochondrial disease variants: Phenotypic and biochemical features analysis in 218 published cases and cohort of 14 new cases.
PMID: 30763462
Hum Mutat · 2019
0.80
4
Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
PMID: 23897027
Acta Neuropathol · 2013
0.70
5
An in vitro system to silence mitochondrial gene expression.
PMID: 34672953
Cell · 2021
0.60